about
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...
Read More
1.14
0.00
(0.00%)
38,354
XNAS Volume
XNAS 27 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Boundless Bio Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..